BRPI1015310A2 - derivados de 2-hidróxi-etil-1h-quinolin-2-ona e seus análogos azaisoestéricos com atividade antibacteriana - Google Patents

derivados de 2-hidróxi-etil-1h-quinolin-2-ona e seus análogos azaisoestéricos com atividade antibacteriana

Info

Publication number
BRPI1015310A2
BRPI1015310A2 BRPI1015310A BRPI1015310A BRPI1015310A2 BR PI1015310 A2 BRPI1015310 A2 BR PI1015310A2 BR PI1015310 A BRPI1015310 A BR PI1015310A BR PI1015310 A BRPI1015310 A BR PI1015310A BR PI1015310 A2 BRPI1015310 A2 BR PI1015310A2
Authority
BR
Brazil
Prior art keywords
azaisosteric
quinolin
analogs
hydroxy
derivatives
Prior art date
Application number
BRPI1015310A
Other languages
English (en)
Inventor
Christian Hubschwerlen
Cornelia Zumbrunn Acklin
Georg Rueedi
Jean-Philippe Surivet
Original Assignee
Acetlion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acetlion Pharmaceuticals Ltd filed Critical Acetlion Pharmaceuticals Ltd
Publication of BRPI1015310A2 publication Critical patent/BRPI1015310A2/pt
Publication of BRPI1015310A8 publication Critical patent/BRPI1015310A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BRPI1015310A 2009-04-09 2010-04-08 Derivados de 2-hidróxi-etil-1h-quinolin-2-ona e seus análogos azaisoestéricos com atividade antibacteriana BRPI1015310A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2009051510 2009-04-09
PCT/IB2010/051517 WO2010116337A1 (en) 2009-04-09 2010-04-08 2-hydroxyethyl-1h-quinolin-2-one derivatives and their azaisosteric analogues with antibacterial activity

Publications (2)

Publication Number Publication Date
BRPI1015310A2 true BRPI1015310A2 (pt) 2016-05-24
BRPI1015310A8 BRPI1015310A8 (pt) 2017-12-26

Family

ID=42199672

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1015310A BRPI1015310A8 (pt) 2009-04-09 2010-04-08 Derivados de 2-hidróxi-etil-1h-quinolin-2-ona e seus análogos azaisoestéricos com atividade antibacteriana

Country Status (15)

Country Link
US (1) US8415375B2 (pt)
EP (1) EP2417141B1 (pt)
JP (1) JP5639639B2 (pt)
KR (1) KR101729345B1 (pt)
CN (1) CN102361875B (pt)
AR (1) AR076222A1 (pt)
AU (1) AU2010233387B2 (pt)
BR (1) BRPI1015310A8 (pt)
CA (1) CA2756727C (pt)
ES (1) ES2438742T3 (pt)
MX (1) MX2011010358A (pt)
PL (1) PL2417141T3 (pt)
RU (1) RU2540862C2 (pt)
TW (1) TWI455937B (pt)
WO (1) WO2010116337A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR076222A1 (es) 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen
AU2012275499A1 (en) * 2011-06-27 2013-12-19 Kyorin Pharmaceutical Co., Ltd. Bridged bicyclic compounds for the treatment of bacterial infections
WO2013038374A1 (en) 2011-09-16 2013-03-21 Actelion Pharmaceuticals Ltd Process for manufacturing a synthetic intermediate
TW201833120A (zh) 2017-02-17 2018-09-16 瑞士商愛杜西亞製藥有限公司 芳基噁唑啶酮抗生素化合物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1095611A1 (ru) * 1982-09-10 2007-06-27 Краснодарский ордена Трудового Красного Знамени политехнический институт Хлорид 5-хлорметил-2-этил-8-метил-4Н-м-диоксино-(4,5-с)-пиридиния, обладающий антимикробной активностью
EG20543A (en) * 1992-10-30 1999-07-31 Procter & Gamble Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones
WO1998007703A1 (fr) * 1996-08-22 1998-02-26 Meiji Seika Kaisha, Ltd. Derives quinoleine et agent psychotrope
GB0112834D0 (en) * 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
AR040335A1 (es) * 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de ciclohexano o ciclohexeno, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento y compuestos intermediarios de utilidad para preparar dicho compuesto
JP2008502689A (ja) 2004-06-15 2008-01-31 グラクソ　グループ　リミテッド 抗菌剤
JP4887297B2 (ja) 2004-09-24 2012-02-29 アクテリオン ファーマシューティカルズ リミテッド 新規二環式抗生物質
EP1888574B1 (en) * 2005-05-25 2009-09-02 Actelion Pharmaceuticals Ltd. New antibiotic derivatives
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
JP5398984B2 (ja) * 2005-06-24 2014-01-29 富山化学工業株式会社 新規な含窒素複素環化合物およびその塩
CN101341126A (zh) * 2005-10-13 2009-01-07 莫弗凯姆联合化学股份公司 具有抗菌活性的5-喹啉衍生物
JP5171618B2 (ja) * 2006-05-26 2013-03-27 富山化学工業株式会社 新規な複素環化合物またはその塩ならびにその中間体
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
WO2008071981A1 (en) 2006-12-15 2008-06-19 Astrazeneca Ab Piperidines for the treatment of bacterial infections
WO2008071962A1 (en) 2006-12-15 2008-06-19 Astrazeneca Ab Pteridines and pyrimidinopyridines as antibacterial agents
WO2008071964A1 (en) 2006-12-15 2008-06-19 Astrazeneca Ab Naphthyridine bactericides
TW200831517A (en) 2006-12-15 2008-08-01 Astrazeneca Ab Chemical compounds
SI2137196T1 (sl) 2007-04-20 2011-01-31 Glaxo Group Ltd Glaxo Welcome House Tricikliäśne spojine, ki vsebujejo duĺ ik, uporabne kot antibakterijska sredstva
EP2005995A1 (en) 2007-06-22 2008-12-24 Glaxo Group Limited Heterocyclic compounds for the treatment of tuberculosis
WO2009001126A1 (en) 2007-06-27 2008-12-31 Astrazeneca Ab Substituted piperidine derivatives and their use as antibaterial agents
GB0800367D0 (en) 2008-01-09 2008-02-20 Glaxo Group Ltd Compounds
BRPI0908208A2 (pt) 2008-02-22 2015-08-25 Actelion Pharmaceuticals Ltd Composto derivado de oxazolidinona, medicamento, composição farmacêutica que o contém e uso desse composto.
EP2297107B1 (en) 2008-06-03 2013-11-13 Actelion Pharmaceuticals Ltd. [4-(1-amino-ethyl) -cyclohexyl]-methyl-amine and [6-(1-amino-ethyl) -tetrahydro- pyran-3-yl]-methyl-amine derivatives as antibacterials
AU2009302007B2 (en) 2008-10-10 2015-01-15 Actelion Pharmaceuticals Ltd Oxazolidinyl antibiotics
MX2011005905A (es) 2008-12-12 2011-06-20 Actelion Pharmaceuticals Ltd Derivados de 5-amino-2-(1-hidroxi-etil)-tetrahidropirano.
AR076222A1 (es) 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen

Also Published As

Publication number Publication date
CN102361875B (zh) 2014-08-20
JP2012523407A (ja) 2012-10-04
CN102361875A (zh) 2012-02-22
KR101729345B1 (ko) 2017-04-21
EP2417141B1 (en) 2013-10-16
US8415375B2 (en) 2013-04-09
AU2010233387B2 (en) 2015-01-15
AU2010233387A1 (en) 2011-11-24
CA2756727C (en) 2017-05-02
RU2011145052A (ru) 2013-05-20
BRPI1015310A8 (pt) 2017-12-26
ES2438742T3 (es) 2014-01-20
RU2540862C2 (ru) 2015-02-10
TW201040182A (en) 2010-11-16
TWI455937B (zh) 2014-10-11
MX2011010358A (es) 2011-11-01
AR076222A1 (es) 2011-05-26
CA2756727A1 (en) 2010-10-14
JP5639639B2 (ja) 2014-12-10
US20120040989A1 (en) 2012-02-16
KR20120014240A (ko) 2012-02-16
PL2417141T3 (pl) 2014-03-31
WO2010116337A1 (en) 2010-10-14
EP2417141A1 (en) 2012-02-15

Similar Documents

Publication Publication Date Title
CY2023012I1 (el) Παραγωγα κινολιν-8-σουλφοναμιδιου εχοντα αντικαρκινικη δραση
BRPI0920183A2 (pt) derivados de fenetilamida e seus analogos heterociclicos
BR112012000660A2 (pt) compostos heterociclos e seus usos
BR112012003870A2 (pt) derivados de sulfeto substituídos com 3-triazolilfenila como acaricidas e inseticidas
DK2773334T3 (da) Sammensætning med forlænget antimikrobiel aktivitet
CR20130403A (es) Derivados de fluoro-piridinona útiles como agentes antibacterianos
BR112013006272A2 (pt) compostos de piridina e seus usos
BR112012010226A2 (pt) artigo absorvente descartável com núcleo absorvente com perfil traçado
BR112013033434A2 (pt) artigo absorvente com estrutura de captação
BR112012005016A2 (pt) artigo absorvente
BRPI1008299A2 (pt) artigo absorvente
BRPI0814231A2 (pt) Derivados de pleuromutilina e seu uso como antimicrobianos
BR112013007617A2 (pt) artigo absorvente com loção
BRPI0920502A2 (pt) compostos cicloundecadepsipeptídeos e seu uso como medicamento
DK2380892T3 (da) Imidazothiazolderivat med prolinringstruktur
BRPI1006506A2 (pt) artigo absorvente
BR112013012120A2 (pt) composições com atividade antibacteriana e de cicatrização de feridas
BRPI1015310A2 (pt) derivados de 2-hidróxi-etil-1h-quinolin-2-ona e seus análogos azaisoestéricos com atividade antibacteriana
BR112013016648A2 (pt) composição tendo atividade antimicrobiana durável
BR112012003970A2 (pt) N-alcoxicarboxamidas e seu uso como microbicidas
BR112012007882A2 (pt) dionas cíclicas de heteroarila substituída ou seus derivados herbicidamente ativos
BRPI0923996A2 (pt) artigo absorvente
DK2379587T3 (da) Melanocortinanaloge med antimikrobiel virkning
BRPI1010192A2 (pt) construção de artigo absorvente simplificada
BRPI1013544A2 (pt) compostos com efeito fisiológico

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25A Requested transfer of rights approved

Owner name: IDORSIA PHARMACEUTICALS LTD (CH)

B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: ACTELION PHARMACEUTICALS LTD (CH)

B25C Requirement related to requested transfer of rights

Owner name: ACTELION PHARMACEUTICALS LTD (CH)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: IDORSIA PHARMACEUTICALS LTD (CH)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements